1. Escobar MF, Nassar AH, Theron G, Barnea ER, Nicholson W, Ramasauskaite D, et al. FIGO recommendations on the management of postpartum hemorrhage 2022. Int J Gynaecol Obstet. 2022; 157(Suppl 1):3–50.
Article
2. Bu SW, Alas-Pineda C, Aguilar-Andino D, Norwood DA, Gaitán-Zambrano K, Pinto-Romero M. Intraumbilical versus intramuscular oxytocin in the management of the third stage of labor. Obstet Gynecol Sci. 2023; 66:76–83.
Article
3. Kumar A. Monument of love or symbol of maternal death: the story behind the Taj Mahal. CRWH. 2014; 1:4–7.
Article
4. Gallos ID, Coomarasamy A. Carbetocin: worth the extra expense? Best Pract Res Clin Obstet Gynaecol. 2019; 61:55–65.
Article
5. Sheldon WR, Blum J, Vogel JP, Souza JP, Gülmezoglu AM, Winikoff B. Postpartum haemorrhage management, risks, and maternal outcomes: findings from the World Health Organization Multicountry Survey on Maternal and Newborn Health. BJOG. 2014; 121(Suppl 1):5–13.
Article
7. Sultana N, Begum F, Shermin S. Active management of the third stage of labour: a brief review and update. Bangladesh J Obstet Gynaecol. 2018; 33:149–56.
Article
8. Vogel JP, Williams M, Gallos I, Althabe F, Oladapo OT. WHO recommendations on uterotonics for postpartum haemorrhage prevention: what works, and which one? BMJ Glob Health. 2019; 4:e001466.
Article
9. Weeks AD, Baskett TF. Postpartumhaemorrhage. Anukumaran S, Robson M, editors. Munro kerr’s operative obstetrics e-book. 13th ed. New York: Elsevier;2019. p. 225–33.
10. Musa AO, Ijaiya MA, Saidu R, Aboyeji AP, Jimoh AA, Adesina KT, et al. Double-blind randomized controlled trial comparing misoprostol and oxytocin for management of the third stage of labor in a Nigerian hospital. Int J Gynaecol Obstet. 2015; 129:227–30.
Article
11. Charan J, Biswas T. How to calculate sample size for different study designs in medical research? Indian J Psychol Med. 2013; 35:121–6.
Article
12. Ambardekar S, Shochet T, Bracken H, Coyaji K, Winikoff B. Calibrated delivery drape versus indirect gravimetric technique for the measurement of blood loss after delivery: a randomized trial. BMC Pregnancy Childbirth. 2014; 14:276.
Article
13. Uthman SG, Garba MA, Danazumi AG, Mandara MU, Sylvester NH. Comparative study of the side effect profiles of oral misoprostol and parenteral oxytocin used in prevention of postpartum haemorrhage in Maiduguri Nigeria. Open J Obstet Gynecol. 2013; 3:208–11.
Article
14. Pangeni PR, Dhungana PR, Adhikari R. A comparative study: is misoprostol as effective as oxytocin in active management of third stage of labor? MJPAHS. 2020; 3:272–6.
Article
15. Abd Allah WA, Hassan FI, Mohamed MF. Oral misoprostol versus intramuscular oxytocin in the active management of the third stage of labour. AMJ. 2021; 50:367–76.
Article
16. Mishra S, Tirkey S, Prasad A, Trivedi K. A comparative study of sublingual misoprostol versus intramuscular oxytocin in the active management of third stage of labor. Cureus. 2023; 15:e33339.
Article
17. Torloni MR, Gomes Freitas C, Kartoglu UH, Metin Gülmezoglu A, Widmer M. Quality of oxytocin available in low- and middle-income countries: a systematic review of the literature. BJOG. 2016; 123:2076–86.
Article
18. Torloni MR, Bonet M, Betrán AP, Ribeiro-do-Valle CC, Widmer M. Quality of medicines for life-threatening pregnancy complications in low- and middle-income countries: a systematic review. PLoS One. 2020; 15:e0236060.
Article
19. Kaudel S, Rana A, Ojha N. Comparison of oral misoprostol with intramuscular oxytocin in the active management of third stage of labour. NJOG. 2015; 10:76–80.
Article
20. Lumbiganon P, Villar J, Piaggio G, Gülmezoglu AM, Adetoro L, Carroli G. Side effects of oral misoprostol during the first 24 hours after administration in the third stage of labour. BJOG. 2002; 109:1222–6.
Article